Lucille Desallais

Active immunization, Interleukin-6, Interleukin-1β, Peptide, Chronic inflammatory diseases

Jean-François Zagury	grad student	2013	Paris, CNAM
(Immunisation active à base de peptides, dérivés de l’IL-6 et de l’IL-1?, dans les maladies inflammatoires chroniques)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Mouhsine H, Guillemain H, Moreau G, et al. (2017) Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening. Scientific Reports. 7: 3424
Desallais L, Bouchez C, Mouhsine H, et al. (2016) Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys. Scientific Reports. 6: 19549
Desallais L, Bouchez C, Mouhsine H, et al. (2016) Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys Scientific Reports. 6
Desallais L, Avouac J, Fréchet M, et al. (2014) Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis. Arthritis Research & Therapy. 16: R157
Avouac J, Desallais L, Fréchet M, et al. (2014) OP0139 Targeting IL-6 by Both Passive or Active Immunization Strategies Prevents Inflammation-Driven Skin Fibrosis Annals of the Rheumatic Diseases. 73: 113.1-113